As shown in Fig. 3, the improvement in sensitivity was almost exclusively due to the inclusion of p31 and p34 in the enhanced IgM assay, which was particularly useful for detecting patients with early Lyme Disease. This evidence concerns the gene CD40LG and Lyme disease.